A prospective, non-randomized study comparing RCS (n = 30) and LCS surgery (n = 120) for early gastric adenocarcinoma reported a lower postoperative CRP and interleukin-6 response in the LCS group. The gene discussed is IL6; the disease is gastric adenocarcinoma.